Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. AVEED® (testosterone undecanoate) injection, for intramuscular use CIII [package insert]. Malvern, PA: Endo Pharmaceuticals Inc.; 2019.
2. AVEED® (testosterone undecanoate) for testosterone replacement for treatment of hypogogonadism. Briefing document for joint meeting of reproductive health drug advisory committee and drug safety risk management advisory committee. Endo Pharmaceuticals Solutions Inc./FDA; 2013. https://www.scribd.com/document/211471259/AVEED-Testosterone-Undecanoate-UCM348092.
3. Krakowsky Y, Conners W, Davidson E, Rawji A, Morgentaler A. Initial clinical experience with testosterone undecanoate therapy (AVEED) in men with testosterone deficiency in the United States. Urology. 2017;109:27–31.
4. Morgentaler A, Dobs AS, Kaufman JM, Miner MM, Shabsigh R, Swerdloff RS, et al. Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study. J Urol. 2008;180:2307–13.
5. Middleton T, Turner L, Fennell C, Savkovic S, Jayadev V, Conway AJ, et al. Complications of injectable testosterone undecanoate in routine clinical practice. Eur J Endocrinol. 2015;172:511–7.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献